Skip to main content

AGC Pharma Chemicals will be attending the 54th Organic Process Research and Development Conference in Lisbon from September 29 to October 1, 2025. This premier gathering of process chemists and R&D professionals offers a rich agenda of technical insights and knowledge sharing.

Our experts will be present to engage with industry peers and discuss how we support pharma companies in process development, scale-up, and technology transfer.

With expertise in complex synthesis and API production, our capabilities are designed to meet the challenges of modern drug development under the highest quality and safety standards.

We’re looking forward to connecting with key players in the R&D community and gaining valuable insights to continue driving innovation in our services.

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon
26th September 2025

AGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon

AGC Pharma Chemicals will be attending the 54th Organic Process Research and Development Conference in Lisbon from September 29 to October 1, 2025. This premier gathering of process chemists and…
NoticiasAGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros
25th September 2025

AGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros

AGC Pharma Chemicals inaugurated its new state-of-the-art manufacturing plant in Malgrat de Mar, Barcelona, representing an investment of over 100 million euros. The new facility marks a key milestone in…
All of ArticlesCDMO ProcessesThe Power of Small Particles: Understanding Micronization in Small Molecule APIs
26th June 2025

The Power of Small Particles: Understanding Micronization in Small Molecule APIs

Did you know that over 70% of new drug molecules face significant bioavailability challenges? The Paradigm Shift in Pharma With over 30% of active pharmaceutical ingredients (APIs) requiring micronization and…